Nomura Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Nomura Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,532	Closed	-$336K	–	1541
2018 Q2	$336K	Sell	3,532 -30,000	-89%	-$2.76M	﹤0.01%	1096
2018 Q1	$2.95M	Buy	33,532 +28,860	+618%	+$2.63M	0.01%	720
2017 Q4	$397K	Buy	+4,672	New	+$391K	﹤0.01%	1360
2017 Q3	–	Sell	-25,000	Closed	-$1.91M	–	1638
2017 Q2	$1.91M	Buy	+25,000	New	+$1.77M	﹤0.01%	848
2016 Q3	–	Sell	-55,253	Closed	-$3.42M	–	1408
2016 Q2	$2.98M	Buy	+55,253	New	+$3.03M	0.01%	562

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Nomura Holdings's XBI Position: Q3 2018 in Review

Nomura Holdings sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2018, closing a stake of 3,532 shares — an estimated $336K sold.

Nomura Holdings first reported a position in XBI in Q2 2016 and held it in 5 quarters. The position peaked at $2.98M in Q2 2016. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

Nomura Holdings reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2018 after selling out during the quarter.
Nomura Holdings sold 3,532 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $336K.
Nomura Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 5 quarters.
Nomura Holdings's State Street SPDR S&P Biotech ETF position peaked at $2.98M in Q2 2016.
432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on Nomura Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.